Evidence map›Paper›PMID 37962471›Full record

ArticleIUCrJ2024

Unravelling the components of diffuse scattering using deep learning.

Chloe A Fuller, Lucas S P Rudden

Open access · goldAbstract read
In one paragraph

Article in IUCrJ, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 58% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Chloe A FullerSwiss-Norwegian Beamlines, ESRF, Grenoble, France.
Lucas S P RuddenInstitute of Bioengineering, EPFL, Lausanne, Switzerland.ORCID 0000-0002-4753-8890
École Polytechnique Fédérale de Lausanne · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many technologically important material properties are underpinned by disorder and short-range structural correlations; therefore, elucidating structure-property relationships in functional materials requires understanding both the average and the local structures. The latter information is contained within diffuse scattering but is challenging to exploit, particularly in single-crystal systems. Separation of the diffuse scattering into its constituent components can greatly simplify analysis and allows for quantitative parameters describing the disorder to be extracted directly. Here, a deep-learning method, DSFU-Net, is presented based on the Pix2Pix generative adversarial network, which takes a plane of diffuse scattering as input and factorizes it into the contributions from the molecular form factor and the chemical short-range order. DSFU-Net was trained on 198 421 samples of simulated diffuse scattering data and performed extremely well on the unseen simulated validation dataset in this work. On a real experimental example, DSFU-Net successfully reproduced the two components with a quality sufficient to distinguish between similar structural models based on the form factor and to refine short-range-order parameters, achieving values comparable to other established methods. This new approach could streamline the analysis of diffuse scattering as it requires minimal prior knowledge of the system, allows access to both components in seconds and is able to compensate for small regions with missing data. DSFU-Net is freely available for use and represents a first step towards an automated workflow for the analysis of single-crystal diffuse scattering.

Indexed as

computational modellingdeep learningdiffuse scatteringdisordermolecular crystalsmolecular form factorsPix2Pix generative adversarial networksshort-range order

Identifiers

PMID37962471
PMCPMC10833394
OpenAlexW4388668648

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.